Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect

Innate Immunity

Volumn 17, Issue 3, 2011, Pages 327-337

  Henning, María F ^a   Herlax, Vanesa ^a   Bakás, Laura ^a,b  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

ANS; ASD LPS; GdnHCl denaturation; lipoprotein; TNF alpha

Indexed keywords

APOLIPOPROTEIN A1; BACTERIUM LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANIMALS; APOLIPOPROTEIN A-I; AZIDES; CELL LINE; ENDOTOXEMIA; ENDOTOXINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 79957922879     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910370709     Document Type: Article

References (45)

1. Wu A., Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004 ; 21: 210-221.
2. van Leeuwen HJ, Heezius EC, Dallinga GM et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003 ; 31: 1359-1366. (Pubitemid 36583844)
3. Liao XL, Ma J., Lou B. et al. Alteration of the components in serum high density lipoprotein during the acute phase reaction induced by lipopolysaccharide. Fudan Univ J Med Sci 2004 ; 31: 469-472.
4. Van Lenten BJ, Hama SY, de Beer FC et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995 ; 96: 2758-2767.
5. Parker TS, Levine DM, Chang JC et al. Reconstituted high-density lipoprotein neutralizes Gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 1995 ; 63: 253-258.
6. Gordon BR, Parker TS, Levine DM et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996 ; 24: 584-589. (Pubitemid 26133790)
7. Massamiri T., Tobias PS, Curtiss LK Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I. J Lipid Res 1997 ; 38: 516-525.
8. Park CT, Wright SD Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J Biol Chem 1996 ; 271: 18054-18060. (Pubitemid 26250791)
9. Emancipator K., Csako G., Elin RJ In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 1992 ; 60: 596-601.
10. Yan Y., Li Y., Lou B. et al. Beneficial effects of ApoA-I on LPSinduced acute lung injury and endotoxemia in mice. Life Sci 2006 ; 79: 210-215. (Pubitemid 43737069)
11. Ma XL, Liao B., Wu MP Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim Biophys Sinica 2004 ; 36: 419-424.
12. Tricerri A., Corsico B., Toledo JD et al. Conformation of apolipoprotein AI in reconstituted lipoprotein particles and particle-membrane interaction: effect of cholesterol. Biochim Biophys Acta 1998 ; 1391: 67-78. (Pubitemid 28143975)
13. Aurell C., Wistrom A. Critical aggregation concentrations of Gram-negative bacterial lipopolysaccharides (LPS). Biochem Biophys Res Commun 1998 ; 253: 119-123. (Pubitemid 29015610)
14. Valpuesta J., Goñi F., Macarulla J. Tryptophan fluorescence of mitochondrial complex III reconstituted in phosphatidylcholine bilayers. Arch Biochem Biophys 1987 ; 257: 285-292.
15. Ohnishi M., Kawagishi T. Stopped-flow studies on the chemical modification with N-bromosuccinimide of model compounds of tryptophan residues. J Biochem 1980 ; 87: 273-279.
16. Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of nonpolar binding sites. J Mol Biol 1965 ; 13: 482-495.
17. Lackowicz J. Principles of Fluorescence Spectroscopy. New York: Plenum, 1984.
18. Schmid F. Spectral methods of characterizing protein conformation and conformational changes. In: Creighton TE. (ed) Protein Structure: A Practical Approach. Oxford: IRL, 1989. p 251.
19. Chen Y., Yang J., Martinez H. Determination of the secondary structures of proteins by circular dichroism and optical rotary dispersion. Biochemistry 1972 ; 11: 4120-4131.
20. Wollenweber HW, Morrison DC Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative. J Biol Chem 1985 ; 260: 15068-15074. (Pubitemid 16147993)
21. Ulevitch RJ The preparation and characterization of a radioiodinated bacterial lipopolysaccharide. Immunochemistry 1978 ; 15: 157-164. (Pubitemid 8308826)
22. Karkhanis Y., Zeltner J., Jackson J. et al. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem 1978 ; 85: 595-601. (Pubitemid 9059222)
23. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 ; 227: 680-685.
24. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987 ; 166: 368-379. (Pubitemid 18004907)
25. Hager D., Burgess R. Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal Biochem 1980 ; 109: 76-86. (Pubitemid 11140095)
26. Ohhashi T., Moritani C., Andoh H. et al. Preparative high-yield electroelution of proteins after separation by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and its application to analysis of amino acid sequences and to raise antibodies. J Chromatogr 1991 ; 585: 153-159.
27. Lowry O., Rosebrough N., Farr A. et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 ; 193: 265-275.
28. Burstein EA, Vedenkina NS, Ivkova MN Fluorescence and the location of tryptophan residues in protein molecules. Photochem Photobiol 1973 ; 18: 263-279.
29. Pace C. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol 1986 ; 131: 266-280. (Pubitemid 16002205)
30. Myers J., Pace C., Scholtz J. Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding. Protein Sci 1995 ; 4: 2138-2148.
31. Atkinson D., Small DM Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem 1986 ; 15: 403-456.
32. Dalton M., Swaney J. Structural and functional domains of apolipoprotein AI within high density lipoproteins. J Biol Chem 1993 ; 268: 19274-19283. (Pubitemid 23270699)
33. Brewer Jr HB, Fairwell T., LaRue A. et al. The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun 1978 ; 80: 623-630. (Pubitemid 8275453)
34. Davidson WS, Arnvig-McGuire K., Kennedy A. et al. Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants. Biochemistry 1999 ; 38: 14387-14395.
35. Gursky O., Atkinson D. Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc Natl Acad Sci USA 1996 ; 93: 2991-1995.
36. Roberts LM, Ray MJ, Shih TW et al. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human Apo A-I. Biochemistry 1997 ; 36: 7615-7624. (Pubitemid 27262389)
37. Zhu H., Atkinson D. Conformation and lipid binding of a C-terminal 198-243. peptide of human apolipoprotein A-I. Biochemistry 2007 ; 46: 1624-1634.
38. Palgunachari M., Mishra V., Lund-Katz S. et al. Only the two end helixes of eight tandem amphipathic helical domains of human apoAI have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb Vasc Biol 1996 ; 16: 328-338. (Pubitemid 26056254)
39. Segrest J., Garber D., Brouillette C. et al. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem 1994 ; 45: 303-369. (Pubitemid 24139891)
40. Segrest JP, Jones MK, De Loof H. et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 1992 ; 33: 141-166.
41. Frank P., Marcel Y. Apolipoprotein AI: structure-function relationship. J Lipid Res 2000 ; 41: 853-872.
42. Segrest J., De Loof H., Dohlman J. et al. Amphipathic helix motif: classes and properties. Proteins 1990 ; 8: 103-117. (Pubitemid 20262536)
43. Ji Y., Jonas A. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J Biol Chem 1995 ; 270: 11290-11297.
44. Morrison J., Fidge N., Tozuka M. Determination of the structural domain of apoAI recognized by high density lipoprotein receptors. J Biol Chem 1991 ; 266: 18780-18785.
45. Córsico B., Toledo J., Garda H. Evidence for a central apolipoprotein AI domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles. J Biol Chem 2001 ; 276: 16978-16985.